|
Age, years
|
66 (56–74)
|
66 (56–74)
|
68 (58–75)
|
0.275
|
|
Male, n (%)
|
348 (83)
|
219 (82)
|
129 (85)
|
0.201
|
|
Body mass index, kg/m2
|
26.8 (22.1–29.5)
|
24.5 (22.4–27.3)
|
23.9 (21.8–26.1)
|
0.010
|
|
STE-ACS, n (%)
|
292 (70)
|
191 (71)
|
101 (68)
|
0.457
|
|
Killip class > 1, n (%)
|
74 (18)
|
40 (15)
|
34 (23)
|
0.042
|
|
Infarct-related artery, n (%)
|
|
Left anterior descending coronary artery, n (%)
|
229 (55)
|
150 (56)
|
79 (53)
|
0.562
|
|
Left circumflex coronary artery, n (%)
|
45 (11)
|
29 (11)
|
16 (11)
|
0.979
|
|
Right coronary artery, n (%)
|
143 (34)
|
89 (33)
|
54 (36)
|
0.532
|
|
Multivessel disease, n (%)
|
176 (42)
|
99 (37)
|
77 (52)
|
0.004
|
|
GRACE score > 140, n (%)
|
212 (51)
|
125 (47)
|
87 (58)
|
0.022
|
|
Hypertension, n (%)
|
255 (61)
|
155 (58)
|
100 (67)
|
0.063
|
|
Hypercholesteremia, n (%)
|
160 (38)
|
109 (41)
|
51 (34)
|
0.195
|
|
Systolic blood pressure on admission, mmHg
|
150 (125–170)
|
149 (125–167)
|
153 (124–177)
|
0.806
|
|
Heart rate on admission, bpm
|
76 (64–88)
|
76 (64–88)
|
76 (65–90)
|
0.575
|
|
Laboratory data
|
|
Cre on admission, mg/dl
|
0.84 (0.72–1.00)
|
0.84 (0.73–0.98)
|
0.83 (0.71–1.02)
|
0.720
|
|
eGFR on admission, %
|
67.9 (56.3–81.1)
|
67.3 (55.9–80.0)
|
70.4 (56.3–83.1)
|
0.091
|
|
Peak level of CPK, IU/l
|
1129 (250–2864)
|
1130 (243–2870)
|
1129 (265–2838)
|
0.696
|
|
BNP during stable phase, pg/ml
|
89.2 (35.5–192.7)
|
80.4 (35.4–171.4)
|
101.3 (37.7–209.1)
|
0.007
|
|
hs-CRP during stable phase > 0.1355 mg/dl, n (%)
|
185 (44)
|
115 (43)
|
70 (47)
|
0.393
|
|
Lipid profile on admission
|
|
LDL cholesterol, mg/dl
|
128 (105–152)
|
131 (108–155)
|
124 (102–148)
|
0.114
|
|
HDL cholesterol, mg/dl
|
44 (37–52)
|
43 (37–51)
|
45 (37–52.5)
|
0.131
|
|
Triglycerides, mg/dl
|
118 (75–185)
|
124 (78–197)
|
113 (70–162)
|
0.125
|
|
Medication on discharge, n (%)
|
|
ACE-I or ARB
|
334 (80)
|
210 (78)
|
124 (83)
|
0.233
|
|
β-blocker
|
275 (66)
|
175 (65)
|
100 (67)
|
0.708
|
|
Statin
|
400 (96)
|
258 (96)
|
142 (95)
|
0.632
|
